17:06 , Oct 19, 2018 |  BC Week In Review  |  Financial News

Velicept raises additional $15M in series B

Velicept Therapeutics Inc. (Malvern, Pa.) raised $15 million in a series B round extension led by Samsara BioCapital. Existing investors CDK, Fountain Healthcare, Longitude Venture Partners and Becker Ventures also participated. Becker Ventures is Velicept's...
01:46 , Dec 2, 2015 |  BC Extra  |  Financial News

Velicept raises first tranche of $21M series B

Velicept Therapeutics Inc. (Malvern, Pa.) raised an undisclosed first tranche of a planned $21 million series B round of funding led by CAM Capital and Longitude Capital. Velicept intends to begin a Phase II study...
07:00 , May 6, 2013 |  BC Week In Review  |  Company News

AltheRx board of directors update

AltheRx Pharmaceuticals , Exton, Pa.   Business: Autoimmune, Genitourinary   Appointed: Charles Becker, chairman of Becker Ventures, as chairman; Jeffery O'Donnell, a managing director of BioStar Ventures, as vice chairman; and Anthony Zook, formerly CEO...
07:00 , May 6, 2013 |  BC Week In Review  |  Financial News

AltheRx completes venture financing

AltheRx Pharmaceuticals , Exton, Pa.   Business: Autoimmune, Genitourinary   Date completed: 5/2/13   Type: Venture financing   Raised: $15 million   Investors: Becker Ventures; and other undisclosed investors  ...
07:00 , May 6, 2013 |  BC Week In Review  |  Company News

AltheRx management update

AltheRx Pharmaceuticals , Exton, Pa.   Business: Autoimmune, Genitourinary   Hired: Jim Bennethum, an EVP at Becker Ventures, as CEO and a director; he succeeds Shawn O'Brien, who departed  ...
00:23 , May 3, 2013 |  BC Extra  |  Financial News

AltheRx raises $15M, names new CEO

AltheRx Pharmaceuticals (Exton, Pa.) raised $15 million in a series A round led by existing investor Becker Ventures. Becker's Jim Bennethum also took over as CEO and became a director, replacing Shawn O'Brien, who departed....